On August 5, 2019 VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported that Jeff Baxter, President and CEO, will present at the Canaccord Genuity 39th Annual Growth Conference in Boston, MA, on Thursday, August 8, 2019, at 1:30 PM ET (Press release, VBI Vaccines, AUG 5, 2019, View Source [SID1234538136]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Canaccord Genuity 39th Annual Growth Conference
Date: Thursday, August 8, 2019
Time: 1:30 – 1:55 PM ET
Webcast: View Source

A live webcast of the presentation and a subsequent replay may be accessed by visiting the Investors page of VBI’s website at www.vbivaccines.com. A replay of the webcast will be archived on the company’s website for 90 days following the presentation.